[Response marker to 5-FU after curative surgery in colorectal cancer].
Division of Surgical Oncology, Department of Translational Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences.
Takashi
T
Tsuji
D017024:Chemotherapy, Adjuvant; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000201:enzymology* / Q000473:pathology / Q000601:surgery; D042943:Dihydrouracil Dehydrogenase (NADP) / Q000378:metabolism; D019008:Drug Resistance, Neoplasm; D004742:Enhancer Elements, Genetic / Q000235:genetics; D005472:Fluorouracil / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D009962:Orotate Phosphoribosyltransferase / Q000378:metabolism; D011110:Polymorphism, Genetic; D013939:Thymidine Phosphorylase / Q000378:metabolism; D013940:Thymidylate Synthase / Q000235:genetics / Q000378:metabolism
D042943:Dihydrouracil Dehydrogenase (NADP); D013940:Thymidylate Synthase; D009962:Orotate Phosphoribosyltransferase; D013939:Thymidine Phosphorylase; D005472:Fluorouracil